A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer. A trial of the north central cancer treatment group
Dean H. Gesme Jr., James R. Jett, Dennis D. Schreffler, John Q. Su, James A. Mailliard, John F. Foley, James E. Krook, Andrew W. Maksymiuk, Alan K. Hatfield, Larry P. Ebbert, Delano M. Pfeifle, RoscoeVolume:
71
Year:
1993
Language:
english
Pages:
4
DOI:
10.1002/1097-0142(19930501)71:93.0.co;2-2
File:
PDF, 376 KB
english, 1993